Fulcrum Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.9M | 872k | 6.75 |
| 2023-09-30 | $1.2M | 259k | 4.44 |
| 2023-06-30 | $1.3M | 388k | 3.30 |
| 2023-03-31 | $849k | 298k | 2.85 |
| 2022-12-31 | $2.3M | 315k | 7.28 |
| 2022-06-30 | $1.4M | 284k | 4.90 |
| 2022-03-31 | $5.6M | 238k | 23.65 |
| 2021-12-31 | $1.5M | 85k | 17.70 |
| 2021-09-30 | $1.8M | 63k | 28.20 |
| 2021-03-31 | $169k | 14k | 11.76 |
| 2020-12-31 | $174k | 15k | 11.71 |
| 2019-09-30 | $185k | 28k | 6.64 |